News | Cardiovascular Ultrasound | July 20, 2017

3-D Vascular Ultrasound Quantifies Plaque Burden to Estimate Cardiovascular Risk

Inexpensive and radiation-free technology has potential to become key screening tool for identifying at-risk individuals

3-D Vascular Ultrasound Quantifies Plaque Burden to Estimate Cardiovascular Risk

July 20, 2017 — In a large, first-of-its-kind population, researchers found an experimental technique known as three-dimensional vascular ultrasound (3DVUS) estimated the quantification of plaque burden (in cubic millimeters) as an important addition to conventional risk factor profile in addressing patient risk stratification.

At an average age of 45 years, they found the plaque burden in subjects was more than twice as high in men as in women (63.4 cubic millimeters vs. 25.7), and higher in the femoral arteries, and with increasing age.

The study was published online in The Journal of the American College of Cardiology.   

Researchers explored the bilateral carotid and femoral arteries of 3,860 middle aged participants without prior cardiovascular disease who were employees of the Banco de Santander in Madrid, Spain. This is an ongoing observational prospective cohort study where participants are being followed up for 10 years. The 3DVUS examinations were performed using a new Phillips iU22 ultrasound system equipped with a VL13-5 3D volume–linear array transducer. This equipment will be available in the near future for routine patient care.

The clinical application of 3DVUS techniques is still at the research and development stage, but there are now a number of clinically promising areas including the measurement of plaque. Direct quantification of atherosclerotic plaque volume by 3DVUS is more reproducible than two-dimensional techniques.

“3DVUS is a feasible, reproducible, and novel imaging technique for quantifying early carotid and femoral atherosclerotic burden in large populations,” said the study’s lead author, Valentin Fuster, M.D., Ph.D., director of Mount Sinai Heart and physician-in-chief of The Mount Sinai Hospital. “This novel method is valid for imaging superficial peripheral atherosclerosis burden from early to advanced stages of disease and can be applied to identification of individuals at risk, targeting or monitoring treatment. Further studies are needed, however, to assess the cost utility of this method compared with others when used in large-scale practice settings and population-based epidemiological studies.”

The study is part of an international initiative that is being conducted through partnerships with the National Center for Cardiovascular Research in Spain, the Icahn School of Medicine at Mount Sinai, and the Framingham Heart Study.

For more information: www.mountsinai.org

Related Content

Carestream Receives Vizient Innovative Technology Designation for Touch Prime Ultrasound Systems
News | Ultrasound Imaging | November 22, 2017
Carestream Health announced its Carestream Touch Prime Ultrasound Systems have received a 2017 Innovative Technology...
Light and Ultrasound Waves Allow More Precise Excision of Skin Cancer Tumors

3-D MSOT rendering of a basal cell carcinoma. Image courtesy of Singapore BioImaging Consortium

News | Oncology Diagnostics | November 20, 2017
Scientists and clinicians from Singapore and Germany have successfully used multispectral optoacoustic tomography (MSOT...
DiA Imaging Analysis Partners With GE Healthcare on Automatic Imaging Analysis Tools

LVivo EF analysis software. Image courtesy of DiA Imaging Analysis

News | Ultrasound Imaging | November 20, 2017
DiA Imaging Analysis announced it has signed a multi-year, non-exclusive licensing and professional services agreement...
News | Ultrasound Imaging | November 17, 2017
CIRS Inc. recently announced the acquisition of ATS Laboratories in Bridgeport, Conn. This merger brings together both...
Verathon Introduces BladderScan Prime Plus Portable 3-D Ultrasound
Technology | Ultrasound Imaging | November 16, 2017
Verathon Inc. announced the launch of its new portable 3-D ultrasound instrument, BladderScan Prime Plus. Powered by...
Philips Azurion Image-Guided Therapy Platform Improves Clinical Workflow for Interventional Procedures
News | Angiography | November 15, 2017
Philips announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow...
Study Unveils Brain Changes During Extended Space Missions
News | Neuro Imaging | November 14, 2017
November 14, 2017 — More people today are poised to explore space than ever before; those who do will experience the
Synthetic CT Images Suitable for Prostate Cancer Radiotherapy Planning
News | Treatment Planning | November 14, 2017
Spectronic Medical announced that new data for their MRIPlanner software, generating synthetic computed tomography (sCT...
Siemens Healthineers Introduces Share360 Tailored Service Portfolio
News | Imaging | November 10, 2017
November 10, 2017 — To address the specific needs of...
Konica Minolta Demonstrates Ultrasound Rheumatology Reporting Package at ACR/ARHP Annual Meeting
News | Orthopedic Imaging | November 08, 2017
Konica Minolta Healthcare Americas Inc. presented its ultrasound systems and wireless digital radiology (DR) imaging...
Overlay Init